Literature DB >> 25189687

Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.

Eduard Baco1, Erik Rud2, Osamu Ukimura3, Ljiljana Vlatkovic4, Aud Svindland4, Toru Matsugasumi3, Jean-Christophe Bernhard5, John C Rewcastle3, Heidi B Eggesbø6.   

Abstract

PURPOSE: To evaluate the effect of targeted biopsy (TB) with elastic fused magnetic resonance imaging (MRI) and 3-dimensional transrectal ultrasound (3D-TRUS) guidance in the diagnosis of anterior prostate cancer (APCa). MATERIAL AND
METHOD: A retrospective study was performed on patients who underwent TB with elastic fused MRI/3D-TRUS guidance using a 1.5-T MRI with T2- and diffusion-weighted images. APCa was defined as TB-proven cancer whose MR-imaged center was located anteriorly according to standardized MRI reporting schema. Prostate Imaging Reporting and Data System was used to quantify MRI suspicion. Maximum cancer core length (MCCL), cancer core involvement, primary Gleason grade pattern, and Gleason score (GS) on TB were assessed. A clinically significant cancer on TB was MCCL ≥ 5mm of GS 6 or any cancer with GS ≥ 7. Agreement between TB and radical prostatectomy step sections was assessed for all subjects when possible.
RESULTS: A total of 211 consecutive subjects were included. APCa was found in 81% (170/211). Median (range) of TB per patient, MCCL, and cancer core involvement were 2 (1-5), 10mm (4-23), and 57% (10%-100%), respectively. According to the level of MRI suspicion, positive rate for any cancer vs. clinically significant cancer was 96% (114/119) vs. 86% (102/119) for highly suspicious, 80% (46/57) vs. 68% (39/57) for likely, and 29% (10/35) vs. 20% (7/35) for equivocal, respectively (P = 0.016 and<0.001). Step-section analysis was possible for 70 patients. Concordance of primary Gleason grade pattern and GS between TB and radical prostatectomy was 90% (κ = 0.7) and 77% (κ = 0.64), respectively.
CONCLUSION: TB with elastic fused MRI/3D-TRUS guidance significantly enhanced accuracy in diagnosing clinically significant APCa.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinically significant prostate cancer; Elastic image fusion; Magnetic resonance imaging; Targeted prostate biopsy; Transrectal ultrasound

Mesh:

Year:  2014        PMID: 25189687     DOI: 10.1016/j.urolonc.2014.07.014

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  8 in total

Review 1.  Current trends and new frontiers in focal therapy for localized prostate cancer.

Authors:  Melissa H Mendez; Daniel Y Joh; Rajan Gupta; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

2.  Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.

Authors:  Akhil Muthigi; Abhinav Sidana; Arvin K George; Michael Kongnyuy; Nabeel Shakir; Meet Kadakia; Mahir Maruf; Thomas P Frye; Francesca Mertan; Daniel Su; Maria J Merino; Peter L Choyke; Baris Turkbey; Bradford J Wood; Peter A Pinto
Journal:  Int Urol Nephrol       Date:  2016-06-15       Impact factor: 2.370

3.  Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.

Authors:  Yannick Cerantola; Eléonore Haberer; Jose Torres; Mona Alameldin; Samuel Aronson; Mark Levental; Franck Bladou; Maurice Anidjar
Journal:  World J Urol       Date:  2015-05-17       Impact factor: 4.226

4.  Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer.

Authors:  Jianwei Gao; Lei Li; Xia Liu; Rui Guo; Bin Zhao
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

5.  Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology.

Authors:  Martin J Magers; Tianyu Zhan; Aaron M Udager; John T Wei; Scott A Tomlins; Angela J Wu; Lakshmi P Kunju; Madelyn Lew; Felix Y Feng; Daniel A Hamstra; Javed Siddiqui; Arul M Chinnaiyan; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Brent K Hollenbeck; David C Miller; Ganesh S Palapattu; Hui Jiang; Rohit Mehra
Journal:  Med Oncol       Date:  2015-10-06       Impact factor: 3.064

6.  Accuracy of Elastic Fusion of Prostate Magnetic Resonance and Transrectal Ultrasound Images under Routine Conditions: A Prospective Multi-Operator Study.

Authors:  Paul Moldovan; Corina Udrescu; Emmanuel Ravier; Rémi Souchon; Muriel Rabilloud; Flavie Bratan; Thomas Sanzalone; Fanny Cros; Sébastien Crouzet; Albert Gelet; Olivier Chapet; Olivier Rouvière
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

7.  Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors.

Authors:  Michael Häggman; Pär Dahlman; Mats Ahlberg; Per Liss; Rafaele Cantera Ahlman; Anca Dragomir; Sam Ladjevardi
Journal:  Acta Radiol Open       Date:  2022-03-31

8.  A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies.

Authors:  Manuel Ritter; Niklas Westhoff; Fabian Derigs; Samuel Doryumu; Fabian Tollens; Dominik Nörenberg; Manuel Neuberger; Jost von Hardenberg; Maurice Stephan Michel
Journal:  World J Urol       Date:  2021-11-26       Impact factor: 4.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.